Navigation Links
Female baby boomers with asthma? You may need help
Date:7/31/2014

ARLINGTON HEIGHTS, Ill. (August 1, 2014) Women over the age of 65 face numerous barriers to good health: an increased risk for obesity, greater struggles against poverty and higher rates of asthma with worse health outcomes. An article published in the August issue of Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI), outlines the challenges faced by older women in treating asthma, and offers practical solutions to improve their care.

"Allergists want older women to understand that getting their asthma under control can help them control a range of other adverse health conditions," said allergist Alan Baptist, MD, MPH, lead study author and ACAAI member. "Recent studies have shown that older women with multiple health problems admit that asthma takes a backseat to other conditions. We want them, with the help of their allergists, to view controlling their asthma as a priority."

The article points out that the asthma rate is no greater in older women than in other segments of the population, but that the amount of illness and death is much higher. The asthma death rate among women older than 65 is nearly four times higher than in other groups.

"There is no doubt that women over 65 suffer from asthma much more than men over 65" said allergist James Sublett, MD, ACAAI president-elect. "We hope that women with asthma will be encouraged by their primary care doctor to work with an allergist. Allergists are experts at creating personalized action plans to help patients identify triggers, and offer solutions for coping with asthma."

Some factors affecting the health of older women with asthma include:

Menopause and Hormone Replacement Therapy (HRT) - The risk for women of developing asthma is not affected by menopause, but, in women with preexisting asthma, menopause tends to increase the number of their attacks.
'/>"/>

Contact: Hollis Heavenrich-Jones
hollisheavenrich-jones@acaai.org
847-427-1200
American College of Allergy, Asthma, and Immunology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Female Triathletes May Face Health Problems Such as Incontinence
2. Communication about female condom vital to young adults, UT Arlington researchers say
3. Risk of pregnancy greater with newer method of female sterilization
4. Males and females differ in specific brain structures
5. Penn study reveals genetics impact risk of early menopause among some female smokers
6. Female Veterans Leaving the Military Can Get Help Finding Civilian Careers with Career Confidential’s Mission: Transition Job Kit
7. Female Fitness and Fat Loss Expert, Shawna Kaminski, Uses Hate Mail as Inspiration to Help More People Achieve their Dream of Becoming Fit
8. EZ-P Enables Female Users to Give Urine Samples More Conveniently - Designed by InventHelp Client (DLL-2593)
9. Thinking ourselves into eating more, reinforcing female math stereotypes, and more
10. Scientists far from finish line in understanding anemia in female athletes
11. Female Cellulite Solution Review Released by Health News Wires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... , ... Dental clinicians from Newcastle University, United Kingdom, visited ... more about its integrated approach to diabetes care. , Philip Preshaw, BDS, PhD, ... at Newcastle University, and Susan Bissett, National Institute for Health Research Clinical Research ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... registration for the company’s second Introduction to Hyperbaric Medicine Course. The next UHMS ... aboard the Queen Mary Hotel in Long Beach, CA. The meeting is open ...
(Date:8/31/2015)... ... 2015 , ... CareSource, a nonprofit Ohio-based health plan, has ... Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications and media ... contributed to the company’s rapid growth. As the CareSource business model expands to ...
(Date:8/31/2015)... ... August 31, 2015 , ... In an article published ... Reconstructive Surgery Global Open Journal that discusses the future of 3-D printing technology as ... the future, customized implants, prosthetics, and other 3-D printed tools could be used to ...
(Date:8/31/2015)... NJ (PRWEB) , ... August 31, 2015 , ... NJ Top Docs Presents, Dr. Michael ... and raised in Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don Bosco Prep ... hockey and served as team captain in both sports in his senior year. He ...
Breaking Medicine News(10 mins):Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3
... to maximize a ... woman,s chance for survival., EVERGREEN PARK, Ill., Nov. 16 In ... to,the American Cancer Society. Breast cancer is the most common cancer among,women, ... cancer,death in women, after lung cancer. Little Company of Mary Hospital ...
... Republic of Georgia Drug Agency Approves Protocol for New ... of Bavituximab in Combination ... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage ... and,hepatitis C virus (HCV) infection, today announced that its ...
... ANGELES, Nov. 16 Neutrogena(R), a worldwide leader,in ... announced today that actress Diane Lane has signed ... Ms. Lane is a captivating and inspiring actress ... and daring spirit. In her new,role, she will ...
... antiemetic pharmaceutical drug (suitable for control of vomiting), ... This was the conclusion of clinical tests undertaken ... the results of which have been recently published ... The Oncologist . , Granisetrn is a ...
... Vaccine Efforts Stumble, Millions Remain Without AIDS Treatment ... ... time in,two weeks, clinical researchers working to develop an AIDS vaccine have,announced ... failed -- after Merck,s AIDS vaccine trial was halted last week,when its ...
... new alternative for patients with erosive gastroesophageal reflux disease ... (GERD) who cannot ... division of Wyeth (NYSE: WYE ), announced today that ... For Delayed-Release Oral Suspension, a new addition,to the Protonix family ...
Cached Medicine News:Health News:Web Site Helps Women Evaluate Risk of Breast Cancer 2Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 2Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 3Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 4Health News:Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador 2Health News:Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy 2Health News:AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF 2Health News:Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension 2Health News:Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension 3
(Date:8/31/2015)...  Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), a ... of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, ... four investor conferences in September. , ... Company, LLC Emerging Growth Conference in ... , President & Chief Executive Officer, will present a ...
(Date:8/31/2015)... Israel , August 31, 2015 ... (TASE: BOLT, OTCQX: BLGTY) ("BioLight" or the ... commercializes biomedical innovations in ophthalmology and cancer diagnostics, ... Technologies (TASE: MCTC), has identified several new genetic ... the jawbone in patients treated with bisphosphonate drugs ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... , NEW YORK ... (Sony) announced today that it has acquired iCyt Mission Technology, Inc. ... cell and disease research, through its U.S. subsidiary, Sony Corporation of ... technologies to enter the flow cytometry business in the life science ...
... , Feb. 9 STD Med, Inc., a manufacturer ... is pleased to announce the acquisition of a new 32,000 sq. ... addition to the current footprint of 120,000 sq. ft. "We are ... financial times," said Steven Tallarida , President STD Med, "we ...
Cached Medicine Technology:Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 2Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 3STD Med Inc. Acquires Facility for Manufacturing and Start-Ups 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: